FESOTERODINE FUMARATE

FESOTERODINE FUMARATE was reported 10802 times

FESOTERODINE FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STEROID DEPENDENCE 142 0.1617
1 CATARRH 145 0.1604
2 CARBUNCLE 34 0.1201
3 BURNS SECOND DEGREE 146 0.0831
4 MONOCLONAL IMMUNOGLOBULIN PRESENT 34 0.0447
5 RESIDUAL URINE VOLUME INCREASED 5 0.0424
6 HYPOPNOEA 146 0.0420
7 EMPHYSEMATOUS PYELONEPHRITIS 7 0.0383
8 ALCOHOL POISONING 101 0.0377
9 HYPOTONIC URINARY BLADDER 5 0.0368
10 WRIST DEFORMITY 21 0.0341
11 HYPOTHALAMO-PITUITARY DISORDER 34 0.0233
12 HYPERTONIC BLADDER 65 0.0225
13 BRONCHIECTASIS 148 0.0219
14 BLADDER SPASM 37 0.0197
15 FINE MOTOR DELAY 5 0.0197
16 GINGIVAL PAIN 151 0.0190
17 PAROSMIA 143 0.0189
18 GASTROENTERITIS BACTERIAL 6 0.0182
19 RHINITIS 144 0.0178
20 CARDIAC MURMUR 151 0.0174
21 BLADDER OBSTRUCTION 8 0.0156
22 MEAN PLATELET VOLUME DECREASED 13 0.0155
23 URINARY RETENTION 502 0.0150
24 ABDOMINAL LYMPHADENOPATHY 13 0.0150
25 HYPOHIDROSIS 7 0.0139
26 URINE FLOW DECREASED 33 0.0138
27 MONOCYTE COUNT DECREASED 14 0.0115
28 PULSELESS ELECTRICAL ACTIVITY 47 0.0112
29 FIBROSIS 34 0.0110
30 BLADDER PAIN 33 0.0104
31 URGE INCONTINENCE 9 0.0103
32 DRY MOUTH 823 0.0101
33 BLADDER DILATATION 11 0.0101
34 IMPAIRED QUALITY OF LIFE 129 0.0090
35 BLADDER DISORDER 88 0.0089
36 ANTICHOLINERGIC SYNDROME 14 0.0088
37 URETHRAL PAIN 5 0.0085
38 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 14 0.0084
39 TUBULOINTERSTITIAL NEPHRITIS 156 0.0083
40 BODY HEIGHT DECREASED 88 0.0082
41 APTYALISM 7 0.0082
42 NOCTURIA 99 0.0081
43 BLADDER DISCOMFORT 10 0.0080
44 BLADDER IRRITATION 5 0.0078
45 FORCED EXPIRATORY VOLUME DECREASED 22 0.0078
46 OVERWEIGHT 41 0.0076
47 MICTURITION URGENCY 87 0.0076
48 CYSTITIS INTERSTITIAL 12 0.0075
49 FINGER DEFORMITY 36 0.0074
50 DRY THROAT 73 0.0072
51 FREQUENT BOWEL MOVEMENTS 194 0.0072
52 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 6 0.0071
53 URINARY INCONTINENCE 207 0.0070
54 PAROTITIS 8 0.0069
55 DYSLIPIDAEMIA 35 0.0069
56 IMPAIRED WORK ABILITY 144 0.0067
57 GENITAL ULCERATION 5 0.0065
58 UTERINE PROLAPSE 7 0.0064
59 DYSURIA 218 0.0059
60 URINARY HESITATION 14 0.0059
61 BLADDER DYSFUNCTION 6 0.0058
62 SWOLLEN TONGUE 181 0.0058
63 BLOOD IMMUNOGLOBULIN E INCREASED 14 0.0058
64 PRODUCT BLISTER PACKAGING ISSUE 6 0.0058
65 MICTURITION DISORDER 20 0.0058
66 OBSTRUCTIVE SLEEP APNOEA SYNDROME 8 0.0055
67 POLLAKIURIA 224 0.0054
68 RENAL CYST 41 0.0052
69 TONGUE DRY 7 0.0051
70 BLADDER OPERATION 6 0.0051
71 RED CELL DISTRIBUTION WIDTH INCREASED 21 0.0050
72 RECTAL HAEMORRHAGE 215 0.0050
73 DRUG EFFECT INCOMPLETE 177 0.0049
74 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 9 0.0048
75 CLUMSINESS 13 0.0048
76 NEUROGENIC BLADDER 10 0.0047
77 STRESS URINARY INCONTINENCE 5 0.0046
78 URINARY TRACT OBSTRUCTION 11 0.0046
79 COLITIS ULCERATIVE 207 0.0046
80 NIGHTMARE 159 0.0046
81 EAR PRURITUS 16 0.0046
82 DEMENTIA WITH LEWY BODIES 5 0.0045
83 ENTHESOPATHY 7 0.0045
84 URINARY TRACT DISORDER 20 0.0044
85 SUBILEUS 9 0.0043
86 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 22 0.0043
87 ACCIDENTAL OVERDOSE 156 0.0043
88 ENURESIS 17 0.0042
89 SYSTEMIC LUPUS ERYTHEMATOSUS 149 0.0042
90 NEPHROPATHY 39 0.0042
91 PROSTATIC OPERATION 5 0.0041
92 BONE SWELLING 4 0.0041
93 INCONTINENCE 43 0.0041
94 PURPURA 35 0.0040
95 URINARY BLADDER HAEMORRHAGE 8 0.0038
96 CYSTITIS NONINFECTIVE 5 0.0037
97 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 175 0.0036
98 DECREASED ACTIVITY 39 0.0036
99 VERTIGO 220 0.0036
100 TINNITUS 164 0.0036
101 SPINAL DEFORMITY 6 0.0036
102 URINE OUTPUT INCREASED 9 0.0034
103 DEMENTIA 95 0.0034
104 BRAIN INJURY 34 0.0034
105 NASAL DRYNESS 21 0.0033
106 FOOT DEFORMITY 37 0.0033
107 ESSENTIAL HYPERTENSION 6 0.0033
108 BLADDER PROLAPSE 4 0.0033
109 CYSTITIS 103 0.0032
110 ARTHRITIS 253 0.0032
111 WHITE BLOOD CELLS URINE POSITIVE 6 0.0032
112 HAEMATOCHEZIA 175 0.0032
113 ECZEMA 165 0.0031
114 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
115 HAEMORRHAGE URINARY TRACT 8 0.0031
116 PHARYNGEAL DISORDER 9 0.0031
117 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
118 PRE-EXISTING CONDITION IMPROVED 19 0.0030
119 OESOPHAGEAL PAIN 12 0.0030
120 ANORECTAL DISORDER 6 0.0030
121 RENAL HAEMORRHAGE 6 0.0029
122 JOINT RANGE OF MOTION DECREASED 39 0.0029
123 TENOSYNOVITIS 8 0.0029
124 CHEST INJURY 6 0.0029
125 VERTIGO POSITIONAL 5 0.0029
126 FOOD INTERACTION 5 0.0028
127 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
128 HYPERKINESIA 6 0.0028
129 CATAPLEXY 4 0.0028
130 MEDICATION ERROR 156 0.0028
131 SCIATICA 44 0.0028
132 WHEELCHAIR USER 12 0.0027
133 CATHETER PLACEMENT 5 0.0027
134 ILEUS PARALYTIC 12 0.0027
135 POTENTIATING DRUG INTERACTION 9 0.0027
136 STOMA SITE ERYTHEMA 5 0.0027
137 HEARING IMPAIRED 16 0.0027
138 REBOUND ACID HYPERSECRETION 8 0.0026
139 BRADYPNOEA 7 0.0026
140 PSYCHIATRIC DECOMPENSATION 5 0.0026
141 FAECALOMA 14 0.0026
142 DEEP VEIN THROMBOSIS 166 0.0026
143 DEPRESSIVE SYMPTOM 9 0.0026
144 PROSTATIC DISORDER 14 0.0025
145 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 26 0.0025
146 VOLVULUS 6 0.0025
147 INTENTIONAL PRODUCT USE ISSUE 220 0.0025
148 SPINAL OSTEOARTHRITIS 22 0.0025
149 DYSGEUSIA 184 0.0025
150 JUVENILE IDIOPATHIC ARTHRITIS 6 0.0025
151 OEDEMA MOUTH 8 0.0024
152 FIBULA FRACTURE 7 0.0024
153 LISTLESS 8 0.0024
154 WALKING AID USER 16 0.0024
155 SPINAL STENOSIS 10 0.0024
156 LIP DRY 22 0.0024
157 URINE ABNORMALITY 11 0.0024
158 COLITIS ISCHAEMIC 16 0.0024
159 DYSSTASIA 69 0.0024
160 ANGLE CLOSURE GLAUCOMA 6 0.0023
161 CONSTIPATION 508 0.0023
162 MIXED LIVER INJURY 7 0.0023
163 UTERINE LEIOMYOMA 17 0.0023
164 HYPOACUSIS 100 0.0023
165 PARESIS 5 0.0022
166 BLOOD URINE PRESENT 42 0.0022
167 DRY EYE 109 0.0022
168 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
169 NEPHROGENIC ANAEMIA 10 0.0022
170 CONFUSIONAL STATE 348 0.0022
171 ATYPICAL FEMUR FRACTURE 6 0.0021
172 MIGRAINE 203 0.0021
173 FRUSTRATION TOLERANCE DECREASED 17 0.0021
174 CEREBRAL HAEMATOMA 7 0.0021
175 CONCUSSION 16 0.0021
176 LIMB INJURY 56 0.0021
177 BREATH ODOUR 5 0.0020
178 WRONG PATIENT RECEIVED PRODUCT 6 0.0020
179 HEPATIC STEATOSIS 38 0.0020
180 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
181 GLAUCOMA 39 0.0020
182 EXPIRED DRUG ADMINISTERED 10 0.0020
183 THIRST 36 0.0020
184 PULMONARY EMBOLISM 190 0.0020
185 HYPERPARATHYROIDISM SECONDARY 5 0.0020
186 ACNE CYSTIC 6 0.0020
187 PROSTATITIS 6 0.0020
188 SYNOVITIS 35 0.0019
189 MIDDLE INSOMNIA 36 0.0019
190 BODY TEMPERATURE FLUCTUATION 4 0.0019
191 JOINT STIFFNESS 50 0.0019
192 MOVEMENT DISORDER 61 0.0019
193 PALPITATIONS 219 0.0019
194 PROTEIN TOTAL DECREASED 7 0.0019
195 PEMPHIGOID 14 0.0019
196 OSTEOARTHRITIS 78 0.0018
197 JAW DISORDER 10 0.0018
198 GINGIVAL DISORDER 7 0.0018
199 MENTAL IMPAIRMENT 44 0.0018
200 URINARY TRACT INFECTION 309 0.0018
201 GINGIVAL SWELLING 8 0.0018
202 FAECES HARD 7 0.0018
203 PROSTATOMEGALY 7 0.0018
204 CEREBRAL DISORDER 13 0.0018
205 PYELONEPHRITIS 15 0.0017
206 HAEMOTHORAX 5 0.0017
207 LUMBAR SPINAL STENOSIS 5 0.0017
208 URINE ODOUR ABNORMAL 10 0.0017
209 SKIN INFECTION 19 0.0017
210 ARTHROPATHY 94 0.0017
211 PHARYNGEAL OEDEMA 26 0.0017
212 DYSGRAPHIA 11 0.0017
213 FACIAL BONES FRACTURE 6 0.0017
214 CHEILITIS 9 0.0017
215 HIP SURGERY 9 0.0017
216 MULTIPLE FRACTURES 27 0.0016
217 VISION BLURRED 225 0.0016
218 MASTICATION DISORDER 5 0.0016
219 ANURIA 14 0.0016
220 FREEZING PHENOMENON 6 0.0016
221 FALL 535 0.0016
222 HYDRONEPHROSIS 12 0.0016
223 PRODUCT PRESCRIBING ERROR 38 0.0016
224 ACCIDENT 19 0.0016
225 SOMNOLENCE 320 0.0016
226 CEREBROVASCULAR ACCIDENT 269 0.0016
227 ABDOMINAL DISCOMFORT 266 0.0016
228 ABDOMINAL ADHESIONS 5 0.0016
229 DRUG EFFECT INCREASED 5 0.0016
230 OSTEOPOROSIS 64 0.0016
231 ADVERSE DRUG REACTION 139 0.0015
232 VULVOVAGINAL DRYNESS 5 0.0015
233 BACK DISORDER 25 0.0015
234 POSTURE ABNORMAL 5 0.0015
235 TONGUE DISORDER 11 0.0015
236 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 108 0.0015
237 IMPAIRED DRIVING ABILITY 17 0.0015
238 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
239 SKIN ABRASION 7 0.0015
240 ENDOMETRIOSIS 7 0.0015
241 MUSCLE SPASTICITY 18 0.0015
242 GAIT DISTURBANCE 280 0.0015
243 HICCUPS 12 0.0015
244 BLOOD PRESSURE ABNORMAL 29 0.0015
245 FAECAL INCONTINENCE 7 0.0015
246 HUMERUS FRACTURE 7 0.0015
247 ANAL INCONTINENCE 13 0.0014
248 MULTIPLE SCLEROSIS 69 0.0014
249 ON AND OFF PHENOMENON 8 0.0014
250 SKIN DISORDER 48 0.0014
251 EYE DISORDER 47 0.0014
252 ANAL HAEMORRHAGE 4 0.0014
253 PRODUCT DISPENSING ERROR 31 0.0014
254 SKIN PLAQUE 12 0.0014
255 WRIST FRACTURE 17 0.0014
256 SLEEP APNOEA SYNDROME 27 0.0014
257 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
258 HAEMORRHAGIC STROKE 11 0.0014
259 PERONEAL NERVE PALSY 8 0.0014
260 ABNORMAL SENSATION IN EYE 6 0.0014
261 FRUSTRATION 5 0.0014
262 TEARFULNESS 6 0.0014
263 SPEECH DISORDER 73 0.0014
264 IMMOBILE 6 0.0014
265 HALLUCINATION, VISUAL 29 0.0014
266 COLITIS 52 0.0014
267 CUTANEOUS VASCULITIS 5 0.0014
268 DYSPHEMIA 6 0.0014
269 NEUTROPHIL COUNT INCREASED 14 0.0014
270 FEMORAL NECK FRACTURE 7 0.0014
271 LYMPHOCYTE COUNT DECREASED 24 0.0014
272 CARDIAC FAILURE ACUTE 9 0.0013
273 DECUBITUS ULCER 11 0.0013
274 BALANCE DISORDER 116 0.0013
275 CHOLELITHIASIS 44 0.0013
276 WEIGHT FLUCTUATION 14 0.0013
277 ATYPICAL PNEUMONIA 4 0.0013
278 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
279 HAEMATOCRIT DECREASED 26 0.0013
280 COMMUNICATION DISORDER 5 0.0013
281 PROSTATIC SPECIFIC ANTIGEN INCREASED 18 0.0013
282 ANAL FISSURE 7 0.0013
283 DYSPHONIA 76 0.0013
284 FOOD ALLERGY 10 0.0013
285 ERUCTATION 25 0.0013
286 VITAMIN D DECREASED 11 0.0013
287 DYSPHAGIA 122 0.0013
288 DRUG INEFFECTIVE 1689 0.0013
289 TIBIA FRACTURE 6 0.0013
290 HYSTERECTOMY 11 0.0013
291 SPINAL DISORDER 12 0.0013
292 MEMORY IMPAIRMENT 174 0.0013
293 FOOT FRACTURE 24 0.0013
294 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
295 INTRAOCULAR PRESSURE INCREASED 16 0.0013
296 OBSTRUCTION 5 0.0013
297 THERAPEUTIC RESPONSE UNEXPECTED 56 0.0012
298 FISTULA 14 0.0012
299 VITAMIN B12 DEFICIENCY 5 0.0012
300 HEAD INJURY 39 0.0012
301 COVID-19 216 0.0012
302 HEPATITIS ACUTE 8 0.0012
303 MOUTH HAEMORRHAGE 9 0.0012
304 RENAL PAIN 13 0.0012
305 DEPRESSION 279 0.0012
306 BREAST PAIN 13 0.0012
307 OROPHARYNGEAL DISCOMFORT 11 0.0012
308 MOUTH SWELLING 7 0.0012
309 VEIN DISORDER 6 0.0012
310 APHASIA 36 0.0012
311 BRADYKINESIA 7 0.0012
312 VULVOVAGINAL PRURITUS 6 0.0012
313 BONE DENSITY DECREASED 37 0.0012
314 HEPATIC CYTOLYSIS 15 0.0012
315 BOWEL MOVEMENT IRREGULARITY 9 0.0012
316 HYPOKINESIA 17 0.0012
317 LACERATION 11 0.0012
318 MULTIPLE SCLEROSIS RELAPSE 80 0.0012
319 FRACTURE 22 0.0012
320 CERVICAL VERTEBRAL FRACTURE 4 0.0012
321 PSORIATIC ARTHROPATHY 47 0.0012
322 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
323 PLATELET COUNT INCREASED 15 0.0011
324 HYPERTRANSAMINASAEMIA 8 0.0011
325 CONDITION AGGRAVATED 349 0.0011
326 EXTRASYSTOLES 8 0.0011
327 CEREBRAL INFARCTION 28 0.0011
328 AFFECTIVE DISORDER 9 0.0011
329 DEFAECATION URGENCY 8 0.0011
330 MOBILITY DECREASED 82 0.0011
331 HAEMORRHAGIC ANAEMIA 5 0.0011
332 AMNESIA 74 0.0011
333 COGNITIVE DISORDER 53 0.0011
334 DRUG EFFECT DECREASED 61 0.0011
335 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
336 ILEUS 14 0.0011
337 DIVERTICULUM 8 0.0011
338 RHINITIS ALLERGIC 5 0.0011
339 WEIGHT DECREASED 312 0.0011
340 OROPHARYNGEAL PAIN 103 0.0011
341 LIVER DISORDER 49 0.0011
342 MUSCULOSKELETAL DISORDER 21 0.0011
343 DRUG EFFECT DELAYED 5 0.0011
344 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
345 INTENTIONAL PRODUCT MISUSE 96 0.0011
346 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
347 LUMBAR VERTEBRAL FRACTURE 5 0.0011
348 ORTHOSTATIC HYPOTENSION 19 0.0011
349 LOCAL SWELLING 19 0.0011
350 MACULAR DEGENERATION 13 0.0011
351 RED BLOOD CELL COUNT DECREASED 31 0.0011
352 UROSEPSIS 10 0.0011
353 GASTRIC DISORDER 37 0.0011
354 FLATULENCE 61 0.0011
355 APHONIA 15 0.0011
356 SNEEZING 24 0.0011
357 VAGINAL INFECTION 5 0.0011
358 SEASONAL ALLERGY 15 0.0011
359 SPINAL COLUMN STENOSIS 5 0.0011
360 SPINAL OPERATION 13 0.0011
361 UPPER LIMB FRACTURE 21 0.0011
362 LIP SWELLING 35 0.0010
363 WRONG TECHNIQUE IN DRUG USAGE PROCESS 38 0.0010
364 HERPES VIRUS INFECTION 6 0.0010
365 VULVOVAGINAL PAIN 5 0.0010
366 BRADYCARDIA 55 0.0010
367 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 186 0.0010
368 FIBROMYALGIA 25 0.0010
369 INCORRECT DOSAGE ADMINISTERED 5 0.0010
370 RENAL TUBULAR NECROSIS 10 0.0010
371 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
372 KIDNEY INFECTION 20 0.0010
373 GASTROOESOPHAGEAL REFLUX DISEASE 82 0.0010
374 ONYCHOCLASIS 7 0.0010
375 RESPIRATION ABNORMAL 7 0.0010
376 LYMPHOEDEMA 7 0.0010
377 BACK INJURY 11 0.0010
378 BLOOD ALBUMIN DECREASED 8 0.0010
379 HIP FRACTURE 32 0.0010
380 MUSCLE DISORDER 8 0.0010
381 GAIT INABILITY 33 0.0010
382 EXOSTOSIS 9 0.0010
383 JOINT INJURY 21 0.0010
384 HALLUCINATION 74 0.0010
385 PRESCRIBED OVERDOSE 19 0.0010
386 DRUG DISPENSING ERROR 15 0.0010
387 INCREASED UPPER AIRWAY SECRETION 5 0.0010
388 HYPERAESTHESIA 8 0.0010
389 PAIN IN EXTREMITY 286 0.0010
390 MUSCULOSKELETAL CHEST PAIN 15 0.0010
391 VARICOSE VEIN 5 0.0010
392 LOSS OF CONSCIOUSNESS 124 0.0010
393 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
394 SINUS DISORDER 19 0.0010
395 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
396 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
397 MUSCULOSKELETAL PAIN 49 0.0009
398 PROCTALGIA 6 0.0009
399 COMPRESSION FRACTURE 5 0.0009
400 HYPOAESTHESIA ORAL 14 0.0009
401 BRUXISM 5 0.0009
402 MUSCULAR WEAKNESS 105 0.0009
403 COELIAC DISEASE 9 0.0009
404 BLOOD PRESSURE FLUCTUATION 22 0.0009
405 POLYP 6 0.0009
406 URINE OUTPUT DECREASED 8 0.0009
407 NAIL DISORDER 8 0.0009
408 BODY TEMPERATURE DECREASED 9 0.0009
409 DRUG INTERACTION 145 0.0009
410 GROIN PAIN 8 0.0009
411 INTESTINAL ISCHAEMIA 5 0.0009
412 HYPERKERATOSIS 5 0.0009
413 DIABETES MELLITUS 69 0.0009
414 LIMB DISCOMFORT 28 0.0009
415 DYSPNOEA EXERTIONAL 34 0.0009
416 PELVIC FRACTURE 7 0.0009
417 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
418 CARDIOMEGALY 11 0.0009
419 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
420 MYOSITIS 8 0.0009
421 HYPONATRAEMIA 50 0.0009
422 FLUID RETENTION 45 0.0009
423 NASAL DISCOMFORT 7 0.0009
424 EAR DISCOMFORT 9 0.0009
425 INTERNAL HAEMORRHAGE 10 0.0009
426 TEMPERATURE INTOLERANCE 9 0.0009
427 MUSCULOSKELETAL DISCOMFORT 15 0.0009
428 OEDEMA PERIPHERAL 106 0.0009
429 MUSCLE TIGHTNESS 14 0.0009
430 HYPOMAGNESAEMIA 12 0.0009
431 CATARACT 51 0.0009
432 DEVICE OCCLUSION 12 0.0009
433 PAPULE 6 0.0009
434 JOINT DISLOCATION 9 0.0009
435 BLOOD PRESSURE INCREASED 130 0.0008
436 THROAT IRRITATION 38 0.0008
437 SPINAL COMPRESSION FRACTURE 7 0.0008
438 SPUTUM DISCOLOURED 8 0.0008
439 CHROMATURIA 19 0.0008
440 PRODUCT USE IN UNAPPROVED INDICATION 208 0.0008
441 PRODUCTIVE COUGH 40 0.0008
442 HYPERSOMNIA 24 0.0008
443 DELUSION 13 0.0008
444 BLOOD CHOLESTEROL INCREASED 39 0.0008
445 POOR QUALITY SLEEP 18 0.0008
446 RENAL FAILURE 111 0.0008
447 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
448 DRUG PRESCRIBING ERROR 16 0.0008
449 APHAGIA 4 0.0008
450 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
451 BIPOLAR DISORDER 9 0.0008
452 PLATELET COUNT ABNORMAL 5 0.0008
453 EAR INFECTION 22 0.0008
454 HYPERTENSION 175 0.0008
455 RESTLESS LEGS SYNDROME 15 0.0008
456 BRONCHITIS 61 0.0008
457 HYPOKALAEMIA 38 0.0008
458 MUSCULOSKELETAL STIFFNESS 72 0.0008
459 VITAMIN D DEFICIENCY 8 0.0008
460 OBESITY 13 0.0008
461 ILLNESS 84 0.0008
462 ENCEPHALOPATHY 20 0.0008
463 VITREOUS FLOATERS 8 0.0008
464 DENTAL CARIES 9 0.0008
465 VISUAL ACUITY REDUCED 27 0.0008
466 ABASIA 20 0.0008
467 TACHYPNOEA 11 0.0008
468 INSOMNIA 215 0.0008
469 ABDOMINAL TENDERNESS 4 0.0008
470 BACK PAIN 187 0.0008
471 SUNBURN 6 0.0008
472 CHRONIC KIDNEY DISEASE 61 0.0008
473 THERAPY CESSATION 41 0.0008
474 HEART RATE INCREASED 79 0.0008
475 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
476 HEART RATE IRREGULAR 18 0.0008
477 DIZZINESS 397 0.0008
478 ORAL DISCOMFORT 11 0.0008
479 FEELING ABNORMAL 189 0.0008
480 FACIAL PAIN 7 0.0008
481 NEOPLASM 9 0.0008
482 ENTERITIS 5 0.0008
483 SKIN REACTION 11 0.0008
484 RASH 340 0.0008
485 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
486 HEPATIC ENZYME INCREASED 53 0.0008
487 PYREXIA 269 0.0008
488 DEPRESSED MOOD 41 0.0008
489 ANKLE FRACTURE 12 0.0008
490 RENAL DISORDER 36 0.0008
491 DYSPEPSIA 76 0.0008
492 DIPLOPIA 20 0.0008
493 EYE DISCHARGE 8 0.0008
494 MULTIPLE ALLERGIES 6 0.0008
495 MALAISE 334 0.0008
496 HAEMATURIA 26 0.0008
497 PAIN 466 0.0008
498 SCRATCH 8 0.0008
499 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
500 AGRANULOCYTOSIS 14 0.0008
501 EXPIRED PRODUCT ADMINISTERED 25 0.0008
502 THINKING ABNORMAL 14 0.0008
503 VISUAL IMPAIRMENT 93 0.0007
504 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
505 IRRITABLE BOWEL SYNDROME 16 0.0007
506 BREAST MASS 5 0.0007
507 BLOOD SODIUM DECREASED 14 0.0007
508 RENAL INJURY 22 0.0007
509 THROAT TIGHTNESS 20 0.0007
510 ABDOMINAL PAIN UPPER 152 0.0007
511 SWELLING FACE 48 0.0007
512 RASH GENERALISED 19 0.0007
513 AFFECT LABILITY 7 0.0007
514 DEAFNESS 19 0.0007
515 ASTHENIA 273 0.0007
516 HERNIA 14 0.0007
517 LARGE INTESTINE POLYP 5 0.0007
518 AGEUSIA 18 0.0007
519 HAEMORRHOIDS 14 0.0007
520 CHOKING 14 0.0007
521 INTENTIONAL DRUG MISUSE 15 0.0007
522 OCULAR DISCOMFORT 8 0.0007
523 SENSATION OF FOREIGN BODY 6 0.0007
524 HEART RATE DECREASED 25 0.0007
525 KNEE OPERATION 7 0.0007
526 BLOOD CALCIUM DECREASED 8 0.0007
527 NERVOUSNESS 37 0.0007
528 LIGAMENT SPRAIN 7 0.0007
529 SCAB 8 0.0007
530 ROTATOR CUFF SYNDROME 9 0.0007
531 CARDIAC VALVE DISEASE 4 0.0007
532 LIVER FUNCTION TEST INCREASED 15 0.0007
533 PARALYSIS 10 0.0007
534 CYTOKINE RELEASE SYNDROME 14 0.0007
535 HIATUS HERNIA 9 0.0007
536 HEADACHE 435 0.0007
537 DRUG INTOLERANCE 67 0.0007
538 PANIC REACTION 5 0.0007
539 BLOOD URIC ACID INCREASED 4 0.0007
540 DELIRIUM 24 0.0007
541 ULCER 11 0.0007
542 DYSKINESIA 28 0.0007
543 C-REACTIVE PROTEIN INCREASED 25 0.0007
544 MOTOR DYSFUNCTION 7 0.0007
545 BODY TEMPERATURE INCREASED 14 0.0007
546 MAJOR DEPRESSION 5 0.0007
547 GASTRIC ULCER 13 0.0007
548 ORAL CANDIDIASIS 9 0.0007
549 IMMUNE SYSTEM DISORDER 9 0.0007
550 PULMONARY CONGESTION 9 0.0007
551 RIB FRACTURE 14 0.0007
552 RENAL IMPAIRMENT 57 0.0007
553 HEAD DISCOMFORT 12 0.0007
554 PSYCHIATRIC SYMPTOM 5 0.0007
555 FATIGUE 527 0.0007
556 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
557 TOOTH DISORDER 15 0.0007
558 MALIGNANT MELANOMA 9 0.0007
559 ABDOMINAL DISTENSION 70 0.0007
560 GASTROINTESTINAL INFECTION 6 0.0007
561 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
562 NECK PAIN 37 0.0007
563 ANAPHYLACTIC SHOCK 17 0.0007
564 GINGIVAL BLEEDING 9 0.0007
565 DISORIENTATION 26 0.0007
566 EYE PAIN 37 0.0007
567 FEELING HOT 40 0.0007
568 SLEEP DISORDER 46 0.0007
569 THYROID DISORDER 10 0.0006
570 GENERALISED OEDEMA 8 0.0006
571 ROAD TRAFFIC ACCIDENT 27 0.0006
572 COORDINATION ABNORMAL 9 0.0006
573 PRODUCT ADMINISTRATION ERROR 13 0.0006
574 HEPATIC ENCEPHALOPATHY 6 0.0006
575 CARPAL TUNNEL SYNDROME 9 0.0006
576 CHEST PAIN 119 0.0006
577 OESOPHAGITIS 7 0.0006
578 GASTROINTESTINAL INFLAMMATION 5 0.0006
579 BLINDNESS UNILATERAL 9 0.0006
580 RESPIRATORY DISORDER 19 0.0006
581 ABDOMINAL PAIN LOWER 16 0.0006
582 NEPHROLITHIASIS 29 0.0006
583 FEELING JITTERY 12 0.0006
584 JOINT SWELLING 76 0.0006
585 NERVE INJURY 7 0.0006
586 EOSINOPHILIA 11 0.0006
587 DISCOMFORT 38 0.0006
588 SENSORY LOSS 5 0.0006
589 EYE INFECTION 7 0.0006
590 KNEE ARTHROPLASTY 13 0.0006
591 EMOTIONAL DISORDER 19 0.0006
592 MUSCLE SPASMS 112 0.0006
593 GASTROENTERITIS VIRAL 11 0.0006
594 GASTRIC HAEMORRHAGE 7 0.0006
595 HOSPICE CARE 6 0.0006
596 DEHYDRATION 81 0.0006
597 OFF LABEL USE 531 0.0006
598 INABILITY TO AFFORD MEDICATION 6 0.0006
599 POST PROCEDURAL HAEMORRHAGE 7 0.0006
600 HYPOAESTHESIA 90 0.0006
601 SPINAL FRACTURE 12 0.0006
602 BLOOD IRON DECREASED 7 0.0006
603 ATAXIA 7 0.0006
604 HELICOBACTER INFECTION 6 0.0006
605 INTESTINAL OBSTRUCTION 22 0.0006
606 HYPOTENSION 117 0.0006
607 PERIPHERAL COLDNESS 8 0.0006
608 GLOSSODYNIA 13 0.0006
609 ORAL PAIN 13 0.0006
610 URTICARIA 97 0.0006
611 NERVOUS SYSTEM DISORDER 18 0.0006
612 NEURALGIA 14 0.0006
613 SEPTIC SHOCK 25 0.0006
614 HERPES ZOSTER 33 0.0006
615 CHOLESTASIS 11 0.0006
616 ACUTE RESPIRATORY FAILURE 11 0.0006
617 SYNCOPE 57 0.0006
618 HYPERSENSITIVITY 105 0.0006
619 BLOOD POTASSIUM DECREASED 17 0.0006
620 ATRIAL FIBRILLATION 55 0.0006
621 FLUSHING 57 0.0006
622 PNEUMONIA ASPIRATION 14 0.0006
623 SUBDURAL HAEMATOMA 8 0.0006
624 BURNING SENSATION 39 0.0006
625 PARAESTHESIA ORAL 8 0.0006
626 SKIN LACERATION 6 0.0006
627 OPTIC NEURITIS 5 0.0005
628 ARRHYTHMIA 26 0.0005
629 FEMUR FRACTURE 17 0.0005
630 SWELLING 51 0.0005
631 TOOTH FRACTURE 6 0.0005
632 PNEUMONIA 176 0.0005
633 INCREASED TENDENCY TO BRUISE 5 0.0005
634 BLINDNESS TRANSIENT 4 0.0005
635 TREMOR 90 0.0005
636 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
637 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
638 ASTHMA 61 0.0005
639 DISTURBANCE IN ATTENTION 29 0.0005
640 IMMUNODEFICIENCY 8 0.0005
641 ERYTHEMA MULTIFORME 5 0.0005
642 OXYGEN SATURATION DECREASED 30 0.0005
643 FACE OEDEMA 9 0.0005
644 BEDRIDDEN 7 0.0005
645 HEMIPARESIS 9 0.0005
646 ARTERIOSCLEROSIS 5 0.0005
647 CONTUSION 51 0.0005
648 PRODUCT PACKAGING ISSUE 5 0.0005
649 DERMATITIS CONTACT 6 0.0005
650 EYE HAEMORRHAGE 7 0.0005
651 MYOCARDITIS 6 0.0005
652 ACUTE KIDNEY INJURY 80 0.0005
653 MOUTH ULCERATION 11 0.0005
654 PULMONARY FIBROSIS 10 0.0005
655 CARDIAC ARREST 43 0.0005
656 LOWER LIMB FRACTURE 10 0.0005
657 INFLUENZA 58 0.0005
658 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
659 BLINDNESS 21 0.0005
660 SKIN LESION 14 0.0005
661 ILL-DEFINED DISORDER 31 0.0005
662 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
663 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
664 COVID-19 PNEUMONIA 6 0.0005
665 PERIPHERAL SWELLING 78 0.0005
666 PRODUCT DOSE OMISSION 33 0.0005
667 PRODUCT USE ISSUE 95 0.0005
668 DIVERTICULITIS 14 0.0005
669 DIARRHOEA 326 0.0005
670 HALLUCINATION, AUDITORY 8 0.0005
671 CARDIAC DISORDER 47 0.0005
672 UNEVALUABLE EVENT 38 0.0005
673 ATRIAL FLUTTER 4 0.0005
674 WOUND 14 0.0005
675 HYPOTONIA 5 0.0005
676 MELAENA 11 0.0005
677 COUGH 140 0.0005
678 LOCALISED INFECTION 12 0.0005
679 CELLULITIS 25 0.0005
680 INTERSTITIAL LUNG DISEASE 24 0.0005
681 BURSITIS 6 0.0005
682 HEPATOCELLULAR INJURY 7 0.0005
683 PRESYNCOPE 12 0.0005
684 GENERAL PHYSICAL HEALTH DETERIORATION 57 0.0005
685 EYELID PTOSIS 5 0.0005
686 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
687 GASTROINTESTINAL DISORDER 44 0.0005
688 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
689 AGITATION 36 0.0005
690 ARTHRALGIA 203 0.0005
691 ABNORMAL FAECES 4 0.0005
692 SKELETAL INJURY 5 0.0005
693 FEAR 13 0.0005
694 BACTERIAL INFECTION 9 0.0005
695 TOOTH EXTRACTION 6 0.0005
696 APATHY 7 0.0005
697 RHINORRHOEA 31 0.0005
698 OEDEMA 26 0.0005
699 ATRIAL SEPTAL DEFECT 4 0.0005
700 SURGERY 28 0.0005
701 NASOPHARYNGITIS 88 0.0005
702 MUSCLE TWITCHING 11 0.0005
703 CARDIAC FAILURE 38 0.0005
704 THROMBOSIS 38 0.0005
705 ABNORMAL DREAMS 13 0.0005
706 PULMONARY MASS 7 0.0005
707 COLON CANCER 7 0.0005
708 EATING DISORDER 10 0.0005
709 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
710 HAEMOGLOBIN DECREASED 48 0.0005
711 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
712 BLOOD MAGNESIUM DECREASED 4 0.0005
713 OSTEOPENIA 7 0.0005
714 FAECES DISCOLOURED 10 0.0005
715 PLEURAL EFFUSION 28 0.0005
716 ABDOMINAL PAIN 107 0.0005
717 MENTAL DISORDER 20 0.0005
718 CHEST DISCOMFORT 47 0.0005
719 PAIN IN JAW 13 0.0005
720 SEPSIS 51 0.0005
721 GASTRITIS 12 0.0005
722 STAPHYLOCOCCAL INFECTION 15 0.0005
723 GASTROINTESTINAL PAIN 5 0.0005
724 HYPOXIA 16 0.0005
725 TENDONITIS 7 0.0005
726 PSORIASIS 59 0.0005
727 DYSARTHRIA 17 0.0005
728 DRUG ERUPTION 8 0.0005
729 SINUSITIS 46 0.0004
730 BASAL CELL CARCINOMA 7 0.0004
731 HAIR TEXTURE ABNORMAL 6 0.0004
732 ANXIETY 127 0.0004
733 INTESTINAL PERFORATION 5 0.0004
734 OSTEOMYELITIS 8 0.0004
735 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
736 RESPIRATORY TRACT CONGESTION 7 0.0004
737 CRYING 16 0.0004
738 IMPAIRED GASTRIC EMPTYING 6 0.0004
739 AGGRESSION 22 0.0004
740 MOOD SWINGS 14 0.0004
741 HYPERGLYCAEMIA 16 0.0004
742 END STAGE RENAL DISEASE 8 0.0004
743 WEIGHT INCREASED 98 0.0004
744 CORONARY ARTERY OCCLUSION 6 0.0004
745 RESTLESSNESS 16 0.0004
746 BLOOD PRESSURE DECREASED 29 0.0004
747 SKIN DISCOLOURATION 20 0.0004
748 DYSPNOEA 246 0.0004
749 EYE IRRITATION 25 0.0004
750 PRODUCT SUBSTITUTION ISSUE 25 0.0004
751 BLOOD GLUCOSE ABNORMAL 8 0.0004
752 PERICARDIAL EFFUSION 10 0.0004
753 HUNGER 6 0.0004
754 HYPOPHAGIA 11 0.0004
755 CORONARY ARTERY DISEASE 13 0.0004
756 BLOOD CREATININE INCREASED 28 0.0004
757 APPENDICITIS 4 0.0004
758 CHILLS 50 0.0004
759 INFLAMMATION 22 0.0004
760 NASAL CONGESTION 25 0.0004
761 VOMITING 200 0.0004
762 HOT FLUSH 32 0.0004
763 HAEMATOMA 11 0.0004
764 ALOPECIA 83 0.0004
765 RETCHING 9 0.0004
766 WHEEZING 25 0.0004
767 NEOPLASM MALIGNANT 28 0.0004
768 MUSCLE RIGIDITY 5 0.0004
769 LETHARGY 24 0.0004
770 TACHYCARDIA 37 0.0004
771 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
772 NAUSEA 327 0.0004
773 OVERDOSE 89 0.0004
774 DRY SKIN 55 0.0004
775 HYPERHIDROSIS 53 0.0004
776 NEUROPATHY PERIPHERAL 39 0.0004
777 PARANOIA 7 0.0004
778 PRURITUS 156 0.0004
779 HYPERCALCAEMIA 5 0.0004
780 EYE SWELLING 15 0.0004
781 CYST 5 0.0004
782 PULMONARY OEDEMA 18 0.0004
783 OCULAR HYPERAEMIA 19 0.0004
784 SEIZURE 46 0.0004
785 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
786 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
787 EPISTAXIS 29 0.0004
788 TOOTH LOSS 8 0.0004
789 PELVIC PAIN 7 0.0004
790 CYANOSIS 6 0.0004
791 ANAPHYLACTIC REACTION 21 0.0004
792 STOMATITIS 23 0.0004
793 ABNORMAL BEHAVIOUR 15 0.0004
794 RENAL FAILURE ACUTE 16 0.0004
795 MYALGIA 64 0.0004
796 SENSORY DISTURBANCE 6 0.0004
797 HAEMORRHAGE 39 0.0004
798 ACUTE MYOCARDIAL INFARCTION 11 0.0004
799 SKIN CANCER 8 0.0004
800 SUICIDAL IDEATION 34 0.0004
801 HYPERKALAEMIA 13 0.0004
802 PRURITUS GENERALISED 8 0.0004
803 ERYTHEMA 76 0.0004
804 INCREASED APPETITE 7 0.0004
805 IRRITABILITY 22 0.0004
806 ASPIRATION 4 0.0004
807 INFUSION RELATED REACTION 24 0.0004
808 MENTAL STATUS CHANGES 10 0.0004
809 FEELING COLD 10 0.0004
810 DRUG ADMINISTRATION ERROR 11 0.0004
811 BLOOD UREA INCREASED 6 0.0004
812 SKIN FISSURES 7 0.0004
813 COMA 17 0.0004
814 TYPE 2 DIABETES MELLITUS 12 0.0004
815 PANCREATITIS ACUTE 8 0.0004
816 BLOOD TEST ABNORMAL 5 0.0004
817 CANDIDA INFECTION 6 0.0004
818 LYMPHOPENIA 5 0.0004
819 DECREASED APPETITE 82 0.0004
820 CIRCULATORY COLLAPSE 6 0.0004
821 PRESCRIBED UNDERDOSE 7 0.0004
822 DRUG DOSE OMISSION 58 0.0004
823 PARAESTHESIA 55 0.0003
824 ANGINA PECTORIS 10 0.0003
825 LUNG DISORDER 17 0.0003
826 FEEDING DISORDER 7 0.0003
827 NEOPLASM PROGRESSION 12 0.0003
828 INJECTION SITE HAEMATOMA 5 0.0003
829 HYPOTHYROIDISM 11 0.0003
830 ANHEDONIA 9 0.0003
831 NIGHT SWEATS 11 0.0003
832 INFLUENZA LIKE ILLNESS 28 0.0003
833 ANGIOEDEMA 15 0.0003
834 LYMPHADENOPATHY 12 0.0003
835 BLISTER 19 0.0003
836 CARDIOMYOPATHY 5 0.0003
837 BACTERAEMIA 4 0.0003
838 GALLBLADDER DISORDER 6 0.0003
839 GOUT 6 0.0003
840 LACRIMATION INCREASED 10 0.0003
841 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
842 BONE DISORDER 6 0.0003
843 EPILEPSY 10 0.0003
844 DEVICE RELATED INFECTION 5 0.0003
845 CARDIAC FAILURE CONGESTIVE 26 0.0003
846 EJECTION FRACTION DECREASED 5 0.0003
847 HEPATIC FUNCTION ABNORMAL 12 0.0003
848 THERAPY PARTIAL RESPONDER 5 0.0003
849 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
850 BRAIN FOG 5 0.0003
851 PHOTOPHOBIA 6 0.0003
852 INFECTION 46 0.0003
853 NEUTROPENIA 43 0.0003
854 INTENTIONAL DOSE OMISSION 9 0.0003
855 RASH MACULO-PAPULAR 7 0.0003
856 THERAPEUTIC RESPONSE DECREASED 19 0.0003
857 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
858 POST PROCEDURAL COMPLICATION 6 0.0003
859 SKIN ULCER 8 0.0003
860 EAR PAIN 6 0.0003
861 BLOOD POTASSIUM INCREASED 5 0.0003
862 CEREBRAL HAEMORRHAGE 11 0.0003
863 RESPIRATORY TRACT INFECTION 8 0.0003
864 PRODUCT DOSE OMISSION ISSUE 90 0.0003
865 APPLICATION SITE ERYTHEMA 8 0.0003
866 VENTRICULAR TACHYCARDIA 5 0.0003
867 PRODUCT QUALITY ISSUE 41 0.0003
868 VIRAL INFECTION 10 0.0003
869 COAGULOPATHY 5 0.0003
870 FUNGAL INFECTION 10 0.0003
871 PRODUCT PHYSICAL ISSUE 6 0.0003
872 SUICIDE ATTEMPT 18 0.0003
873 TASTE DISORDER 6 0.0003
874 PNEUMONITIS 8 0.0003
875 MULTI-ORGAN FAILURE 5 0.0003
876 HYPOGLYCAEMIA 14 0.0003
877 PULMONARY HYPERTENSION 6 0.0003
878 HAEMOPTYSIS 8 0.0003
879 OSTEONECROSIS OF JAW 7 0.0003
880 ADVERSE EVENT 26 0.0003
881 PLASMA CELL MYELOMA 11 0.0003
882 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
883 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
884 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
885 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
886 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
887 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
888 WHITE BLOOD CELL COUNT DECREASED 30 0.0003
889 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 56 0.0003
890 PRODUCT PRESCRIBING ISSUE 6 0.0003
891 LIVER FUNCTION TEST ABNORMAL 8 0.0003
892 PANIC ATTACK 10 0.0003
893 HEPATITIS 7 0.0003
894 PROSTATE CANCER 22 0.0003
895 CONJUNCTIVITIS 5 0.0003
896 EYE PRURITUS 9 0.0003
897 BONE LOSS 4 0.0003
898 SKIN BURNING SENSATION 19 0.0003
899 APPLICATION SITE PRURITUS 6 0.0003
900 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
901 DYSTONIA 5 0.0003
902 RASH MACULAR 9 0.0003
903 ORAL HERPES 5 0.0003
904 BONE PAIN 15 0.0003
905 RHEUMATOID ARTHRITIS 29 0.0003
906 BLADDER CANCER 15 0.0003
907 INCORRECT DOSE ADMINISTERED 58 0.0003
908 PROCEDURAL PAIN 7 0.0003
909 ABSCESS 4 0.0003
910 DIABETIC KETOACIDOSIS 6 0.0002
911 FULL BLOOD COUNT DECREASED 5 0.0002
912 BREAST CANCER 23 0.0002
913 UNDERDOSE 18 0.0002
914 BONE MARROW FAILURE 5 0.0002
915 CONVULSION 14 0.0002
916 IMPAIRED HEALING 8 0.0002
917 PANCREATIC CARCINOMA 7 0.0002
918 FEBRILE NEUTROPENIA 16 0.0002
919 PSYCHOTIC DISORDER 7 0.0002
920 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
921 ANAEMIA 45 0.0002
922 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
923 ERECTILE DYSFUNCTION 6 0.0002
924 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
925 EXTRA DOSE ADMINISTERED 9 0.0002
926 NEUTROPHIL COUNT DECREASED 9 0.0002
927 MOOD ALTERED 6 0.0002
928 DISEASE PROGRESSION 26 0.0002
929 LUNG NEOPLASM MALIGNANT 9 0.0002
930 METABOLIC ACIDOSIS 7 0.0002
931 PLATELET COUNT DECREASED 23 0.0002
932 DEATH 185 0.0002
933 TARDIVE DYSKINESIA 6 0.0002
934 MYOCARDIAL INFARCTION 37 0.0002
935 ACNE 16 0.0002
936 BLOOD GLUCOSE DECREASED 10 0.0002
937 VAGINAL HAEMORRHAGE 9 0.0002
938 ANGER 7 0.0002
939 RESPIRATORY FAILURE 15 0.0002
940 TREATMENT FAILURE 17 0.0002
941 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
942 INJECTION SITE URTICARIA 5 0.0002
943 LABORATORY TEST ABNORMAL 6 0.0002
944 RASH PRURITIC 11 0.0002
945 EXTRAPYRAMIDAL DISORDER 5 0.0002
946 INJURY 14 0.0002
947 HAEMATEMESIS 5 0.0002
948 CARDIOVASCULAR DISORDER 5 0.0002
949 PANCYTOPENIA 11 0.0002
950 UNRESPONSIVE TO STIMULI 5 0.0002
951 DRUG-INDUCED LIVER INJURY 6 0.0002
952 BLOOD GLUCOSE INCREASED 36 0.0002
953 DEVICE ISSUE 17 0.0002
954 PAIN OF SKIN 5 0.0002
955 LACTIC ACIDOSIS 6 0.0002
956 BLOOD BILIRUBIN INCREASED 5 0.0002
957 TREATMENT NONCOMPLIANCE 10 0.0002
958 APPLICATION SITE PAIN 4 0.0002
959 DRUG DEPENDENCE 29 0.0002
960 SKIN EXFOLIATION 15 0.0002
961 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
962 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
963 EMOTIONAL DISTRESS 21 0.0002
964 INTENTIONAL OVERDOSE 11 0.0002
965 PANCREATITIS 9 0.0002
966 DISEASE RECURRENCE 8 0.0002
967 RHABDOMYOLYSIS 7 0.0002
968 RASH ERYTHEMATOUS 8 0.0002
969 WITHDRAWAL SYNDROME 7 0.0002
970 THERAPY INTERRUPTED 11 0.0002
971 THROMBOCYTOPENIA 17 0.0002
972 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
973 BREAST CANCER FEMALE 4 0.0001
974 HOSPITALISATION 22 0.0001
975 LEUKOPENIA 7 0.0001
976 DEVICE DISLOCATION 6 0.0001
977 DRUG WITHDRAWAL SYNDROME 12 0.0001
978 INJECTION SITE MASS 5 0.0001
979 DERMATITIS ATOPIC 7 0.0001
980 NO ADVERSE EVENT 24 0.0001
981 SKIN IRRITATION 6 0.0001
982 EXPOSURE DURING PREGNANCY 8 0.0001
983 INJECTION SITE HAEMORRHAGE 10 0.0001
984 CARDIO-RESPIRATORY ARREST 5 0.0001
985 THERAPY NON-RESPONDER 5 0.0001
986 INJECTION SITE PRURITUS 7 0.0001
987 INJECTION SITE ERYTHEMA 11 0.0001
988 INJECTION SITE PAIN 25 0.0001
989 TOXICITY TO VARIOUS AGENTS 13 0.0001
990 INJECTION SITE BRUISING 6 0.0001
991 DEVICE MALFUNCTION 5 0.0001